Works matching IS 11732563 AND DT 2020 AND VI 40 AND IP 7


Results: 11
    1
    3
    4
    5
    6
    7
    8
    9

    Safety, Tolerability, and Pharmacokinetics of SUVN-G3031, a Novel Histamine-3 Receptor Inverse Agonist for the Treatment of Narcolepsy, in Healthy Human Subjects Following Single and Multiple Oral Doses.

    Published in:
    Clinical Drug Investigation, 2020, v. 40, n. 7, p. 603, doi. 10.1007/s40261-020-00920-8
    By:
    • Nirogi, Ramakrishna;
    • Mudigonda, Koteshwara;
    • Bhyrapuneni, Gopinadh;
    • Muddana, Nageswara Rao;
    • Shinde, Anil;
    • Goyal, Vinod Kumar;
    • Pandey, Santosh Kumar;
    • Mohammed, Abdul Rasheed;
    • Ravula, Jyothsna;
    • Jetta, Satish;
    • Palacharla, Veera Raghava Chowdary
    Publication type:
    Article
    10
    11